You are here: Industry Insights > BASF

News List

BASF launches three new active ingredients derived from the rambutan tree cphi-online
April 11, 2019
BASF launches three new active ingredients derived from the rambutan tree
BASF launches first dedicated product to help patients with NAFLD in the US cphi-online
February 26, 2018
BASF's Hepaxa is the first product in the US specifically designed to address a buildup of fat in the liver in NAFLD patients.
BASF in agreement with DIEM Labs expressbpd
November 07, 2017
BASF Corporation and DIEM Labs have entered into a distribution agreement to commercialize BASF’s first US medical food product for the dietary management of patients with Non-Alcoholic Fatty Liver Disease (NAFLD).
BASF to enter medical foods market in the US with DIEM Labs europeanpharmaceuticalreview
November 06, 2017
BASF Corporation and DIEM Labs, LLC. have entered into a distribution agreement to commercialize BASF’s first U.S. medical food product for the dietary management of patients with Non-Alcoholic Fatty Liver Disease (NAFLD)…
BASF expands technical lab for pharma application & technology development in South Asia expressbpd
August 04, 2017
The facility will cater to the fast-growing pharma market in South Asia
BASF plans significant investment in Germany and North America pharmaasia
July 25, 2017
BASF plans significant investment in ibuprofen capacities in Germany and North America.
BASF plans significant investment in ibuprofen capacities in Germany and North America cphi-online
June 30, 2017
New world-scale ibuprofen production plant in Ludwigshafen; additional capacity expansion of ibuprofen plant in Bishop, Texas.
BASF inorganic specialties divestiture creates new business named Callery cphi-online
March 16, 2017
Current product portfolio includes a range of specialty alkoxide bases and borane derivatives.